OTC – Pricing and Valuation
Independent and transparent OTC valuation has become a central requirement for regulated financial institutions. Arkus provides reliable OTC valuation services that support accurate pricing, robust governance and clear regulatory oversight. Our approach enables firms to strengthen internal controls and demonstrate appropriate valuation processes for a wide range of instruments.
More transparency
Reliable pricing for complex instruments
Our services are based on established valuation models, robust pricing methodologies and clearly defined assumptions. We offer both standard OTC instruments and complex or bespoke structures, ensuring consistent and defensible valuation results across portfolios.
Valuations are performed independently and supported by transparent documentation. Our software solution RiskRadar provides a secure environment to review valuation inputs, analyse results and document oversight activities, supporting both operational processes and audit readiness.
Independent OTC valuation
Arkus provides independent OTC valuation supported by documented models, transparent assumptions and consistent valuation techniques.
Clear methodologies and documentation
Our OTC valuation services include access to model documentation and valuation logic, enabling users to review, verify and evidence valuation processes.
Structured and scalable workflows
Arkus supports efficient and repeatable processes that integrate smoothly into existing governance and reporting frameworks.
Recognised market models
Where standard approaches are not sufficient, bespoke modelling can be applied to reflect specific product features.
Data access for validation
Valuation input data can be shared either in full or on a sample basis. This allows clients to validate results, document valuation checks and support internal and external review processes.
Valuation coverage
OTC instruments and asset classes
Tailored solutions
Our OTC valuation services are supported by experienced specialists who guide you from onboarding through to ongoing operations. We work closely with you to ensure smooth integration, clear valuation processes and reliable day-to-day delivery.
You benefit from a direct point of contact and close collaboration with our experts Martin Ewen and Andrea Brevi. We guarantee fast responses, clear communication and dependable support throughout your OTC valuation setup.
Let’s discuss your pricing challenges
Our experts are available for a personal conversation and will be happy to advise you. Book a non-binding consultation!
Contact us